Atria Wealth Solutions Inc. Purchases 2,833 Shares of Aflac Incorporated (NYSE:AFL)

Atria Wealth Solutions Inc. lifted its position in shares of Aflac Incorporated (NYSE:AFL) by 7.5% during the fourth quarter, Holdings Channel.com reports. The firm owned 40,560 shares of the financial services provider’s stock after buying an additional 2,833 shares during the quarter. Atria Wealth Solutions Inc.’s holdings in Aflac were worth $3,346,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently made changes to their positions in AFL. Fortitude Family Office LLC bought a new position in shares of Aflac during the fourth quarter worth approximately $25,000. Bruce G. Allen Investments LLC bought a new position in shares of Aflac during the fourth quarter worth approximately $32,000. Harvest Fund Management Co. Ltd bought a new position in shares of Aflac during the third quarter worth approximately $33,000. Criterion Capital Advisors LLC bought a new position in shares of Aflac during the fourth quarter worth approximately $33,000. Finally, Arlington Trust Co LLC bought a new position in shares of Aflac during the fourth quarter worth approximately $35,000. Institutional investors own 67.44% of the company’s stock.

Analyst Upgrades and Downgrades

AFL has been the topic of a number of analyst reports. Raymond James increased their price target on Aflac from $83.00 to $88.00 and gave the stock an “outperform” rating in a research report on Friday, February 2nd. The Goldman Sachs Group increased their price target on Aflac from $61.00 to $75.00 and gave the stock a “sell” rating in a research report on Tuesday, January 9th. Keefe, Bruyette & Woods increased their price target on Aflac from $83.00 to $87.00 and gave the stock a “market perform” rating in a research report on Wednesday, April 10th. Wells Fargo & Company reduced their price target on Aflac from $83.00 to $81.00 and set an “equal weight” rating on the stock in a research report on Thursday, April 11th. Finally, Piper Sandler increased their price target on Aflac from $90.00 to $95.00 and gave the stock an “overweight” rating in a research report on Friday, April 5th. Three research analysts have rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, Aflac has an average rating of “Hold” and an average target price of $82.15.

Insider Buying and Selling

In related news, Director Arthur Reginald Collins sold 3,000 shares of the business’s stock in a transaction on Thursday, February 22nd. The stock was sold at an average price of $79.73, for a total transaction of $239,190.00. Following the sale, the director now owns 5,592 shares in the company, valued at approximately $445,850.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Aflac news, SVP Albert Riggieri sold 8,000 shares of Aflac stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $83.34, for a total transaction of $666,720.00. Following the transaction, the senior vice president now directly owns 32,825 shares of the company’s stock, valued at approximately $2,735,635.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Arthur Reginald Collins sold 3,000 shares of Aflac stock in a transaction dated Thursday, February 22nd. The stock was sold at an average price of $79.73, for a total value of $239,190.00. Following the transaction, the director now directly owns 5,592 shares in the company, valued at $445,850.16. The disclosure for this sale can be found here. Insiders have sold 46,493 shares of company stock worth $3,765,706 in the last 90 days. Insiders own 0.90% of the company’s stock.

Aflac Trading Down 0.1 %

Shares of AFL stock opened at $83.61 on Friday. The stock’s fifty day moving average price is $82.69 and its two-hundred day moving average price is $81.77. The company has a market cap of $48.11 billion, a PE ratio of 10.79, a P/E/G ratio of 2.30 and a beta of 0.91. Aflac Incorporated has a fifty-two week low of $64.10 and a fifty-two week high of $86.26. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.06 and a current ratio of 0.06.

Aflac (NYSE:AFL) last issued its quarterly earnings data on Thursday, February 1st. The financial services provider reported $1.25 earnings per share for the quarter, missing analysts’ consensus estimates of $1.47 by ($0.22). The firm had revenue of $3.78 billion for the quarter, compared to the consensus estimate of $4.44 billion. Aflac had a return on equity of 17.59% and a net margin of 24.92%. During the same quarter in the prior year, the firm earned $1.29 EPS. Equities analysts predict that Aflac Incorporated will post 6.41 EPS for the current fiscal year.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.